Michael Rose

1.5k total citations
51 papers, 1.0k citations indexed

About

Michael Rose is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Michael Rose has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Surgery and 13 papers in Oncology. Recurrent topics in Michael Rose's work include Bladder and Urothelial Cancer Treatments (19 papers), Epigenetics and DNA Methylation (10 papers) and Urinary and Genital Oncology Studies (8 papers). Michael Rose is often cited by papers focused on Bladder and Urothelial Cancer Treatments (19 papers), Epigenetics and DNA Methylation (10 papers) and Urinary and Genital Oncology Studies (8 papers). Michael Rose collaborates with scholars based in Germany, United States and United Kingdom. Michael Rose's co-authors include Ruth Knüchel, Edgar Dahl, Nadine T. Gaisa, Erik Noetzel, Arndt Hartmann, Axel Heidenreich, Ruth Knuechel, Vera Kloten, Saskia von Stillfried and Angela Maurer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Physical Review Letters and Journal of Biological Chemistry.

In The Last Decade

Michael Rose

49 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Rose Germany 21 515 276 215 191 144 51 1.0k
Makoto Chuma Japan 21 643 1.2× 323 1.2× 197 0.9× 251 1.3× 184 1.3× 70 1.9k
Pablo Conesa‐Zamora Spain 22 480 0.9× 392 1.4× 158 0.7× 248 1.3× 130 0.9× 85 1.3k
Thilo Bracht Germany 21 713 1.4× 178 0.6× 96 0.4× 165 0.9× 112 0.8× 49 1.2k
Sandra Rauser Germany 26 1.2k 2.4× 522 1.9× 217 1.0× 223 1.2× 209 1.5× 33 2.1k
Yasunari Miyagi Japan 21 414 0.8× 354 1.3× 236 1.1× 188 1.0× 42 0.3× 82 1.5k
Cynthia S. Hinck United States 17 939 1.8× 197 0.7× 90 0.4× 96 0.5× 133 0.9× 39 1.2k
Weijing Zhang China 22 496 1.0× 418 1.5× 131 0.6× 251 1.3× 120 0.8× 50 1.2k
Lichao Zhao United States 18 231 0.4× 220 0.8× 88 0.4× 89 0.5× 58 0.4× 32 924
Stefan Vasile United States 19 779 1.5× 230 0.8× 79 0.4× 145 0.8× 143 1.0× 54 1.5k
Weiting Ge China 20 564 1.1× 393 1.4× 121 0.6× 370 1.9× 64 0.4× 56 1.2k

Countries citing papers authored by Michael Rose

Since Specialization
Citations

This map shows the geographic impact of Michael Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rose more than expected).

Fields of papers citing papers by Michael Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rose. The network helps show where Michael Rose may publish in the future.

Co-authorship network of co-authors of Michael Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rose. A scholar is included among the top collaborators of Michael Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rose. Michael Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mantwill, Klaus, Per Sonne Holm, Kristina Schwamborn, et al.. (2025). Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer. Scientific Reports. 15(1). 13443–13443. 1 indexed citations
2.
Shi, Jiaxin, Michael Rose, Lara R. Heij, et al.. (2025). Characterization of ITIH6, a novel inter-α-inhibitor family member with prognostic significance in cholangiocarcinoma. International Journal of Biological Macromolecules. 331(Pt 1). 148360–148360.
3.
Noetzel, Erik, Lin Gan, Ralf Weiskirchen, et al.. (2024). Dual role of GRHL3 in bladder carcinogenesis depending on histological subtypes. Molecular Oncology. 18(6). 1397–1416.
5.
Dahl, Edgar, et al.. (2022). White Paper: Mimetics of Class 2 Tumor Suppressor Proteins as Novel Drug Candidates for Personalized Cancer Therapy. Cancers. 14(18). 4386–4386. 12 indexed citations
6.
Rose, Michael, Sebastian Huth, Josef Ehling, et al.. (2022). ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In Vitro. Cancers. 14(3). 488–488. 5 indexed citations
7.
Knüchel, Ruth, et al.. (2022). Effective Radiosensitization of Bladder Cancer Cells by Pharmacological Inhibition of DNA-PK and ATR. Biomedicines. 10(6). 1277–1277. 7 indexed citations
8.
Rose, Michael, et al.. (2021). Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer. International Journal of Molecular Sciences. 22(21). 11547–11547. 25 indexed citations
9.
Ortiz‐Brüchle, Nadina, Michael Rose, Simone Bertz, et al.. (2021). Molecular Characterization of Muellerian Tumors of the Urinary Tract. Genes. 12(6). 880–880. 7 indexed citations
10.
He, Andy, et al.. (2020). Cryopreservation of Viable Human Tissues: Renewable Resource for Viable Tissue, Cell Lines, and Organoid Development. Biopreservation and Biobanking. 18(3). 222–227. 24 indexed citations
11.
Maurer, Angela, Michael Rose, Robert Stöhr, et al.. (2020). Comparative genomic profiling of glandular bladder tumours. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(3). 445–454. 22 indexed citations
12.
Stillfried, Saskia von, Wiebke Antonopoulos, Arndt Hartmann, et al.. (2015). AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection. PLoS ONE. 10(4). e0122106–e0122106. 40 indexed citations
13.
Rose, Michael, et al.. (2014). Bioburden after Staphylococcus aureus Inoculation in Type 1 Diabetic Rats Undergoing Internal Fixation. Plastic & Reconstructive Surgery. 134(3). 412e–419e. 5 indexed citations
15.
Rose, Michael, Claudia Schubert, Nadine T. Gaisa, et al.. (2014). OASIS/CREB3L1is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migrationin vitro. Epigenetics. 9(12). 1626–1640. 30 indexed citations
17.
Rose, Michael, et al.. (2014). Epigenetic inactivation of ST6GAL1 in human bladder cancer. BMC Cancer. 14(1). 901–901. 38 indexed citations
18.
Kristiansen, Glen, Michael Rose, Carsten Geisler, et al.. (2010). Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype. British Journal of Cancer. 102(12). 1736–1745. 45 indexed citations
19.
Veeck, Jürgen, Michael Rose, Amjad Naami, et al.. (2008). Neuer Prognosemarker beim invasiven Mammakarzinom. Der Pathologe. 29(S2). 338–346. 7 indexed citations
20.
Cox, Robert A., et al.. (1988). The Value of the Pre‐clinic Intravenous Urogram In the Earlier Diagnosis of the Cause of Haematuria. British Journal of Urology. 62(1). 11–12. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026